Healthcare Economics

Recently published articles about Cost and Economics

JCP
Medication Use and Lines of Treatment in Patients With Insomnia Disorder
Original Research

September 11, 2024

In this Canadian study, the annual cost of medications for insomnia was $54.8 million, and $30.3 million (55.2%) met inappropriate medication use criteria.
, , , et al
Weekly Mind Reader: When is Vomiting Not a Gut Problem?
news

August 23, 2024

This week features a report on chronic vomiting, a review of the economic impact of cognitive impairment, and how apps can advance care.
JCP
Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia
Review Article

August 21, 2024

Patients with schizophrenia and cognitive impairment had a 100% increase in relapse-related hospitalizations and ER visits versus patients with no (or only mild) cognitive impairment.
, , , et al
New Study Confirms Causal Link Between Poverty and Mental Illness
news

July 10, 2024

New research confirms that poverty and mental illness are causally linked, with each exerting influence on the other.
JCP
The Long Road Toward Equitable MDMA Treatment in the United States
Commentary

May 29, 2024

Kozak and Aaronson discuss challenges in implementation of MDMA-assisted therapy, including insurance and Medicare coverage as well as cultural barriers.
,
JCP
Fiscal Impact of Schizophrenia From a Government Perspective
Original Research

August 9, 2023

This analysis revealed that the lifetime fiscal loss to the government was $1,540,042 for each person with schizophrenia.
, , , et al

Recent JCP Articles on Cost and Economics

JCP
Synopsis of the VA/DOD Clinical Practice Guideline for Management of Bipolar Disorder
Consensus Statement

January 13, 2025

This synopsis focuses on clinically relevant recommendations related to identification and management of bipolar disorder, including the acute and maintenance phases of illness.
, , , et al
JCP
BI 1358894 in Borderline Personality Disorder
Original Research

January 13, 2025

Although the primary endpoint was not met, BI 1358894 was well-tolerated with no increase in self-harm or suicidality.
, , , et al
JCP
Inpatient Treatment of Suicidality
Systematic Review

January 8, 2025

Effective, rapid treatments that target suicidality in psychiatric inpatients are scarce in the existing literature and in clinical practice, underscoring the need for studies to identify and validate these...
, , , et al

Recent PCC Articles on Cost and Economics

PCC
Original Research

January 14, 2025

This study examined data from a large, nationally representative sample of US veterans to determine the prevalence and correlates of high chronic suicide risk.
, , , et al
PCC
Catatonia Associated With Post-Acute COVID-19 in a Young Child
Case Report

January 9, 2025

A 4-year-old girl with high-functioning autism spectrum disorder experienced catatonia associated with the post-acute phase of SARS-CoV-2 infection.
, ,
PCC
Sodium Valproate–Associated Psoriasis
Case Report

January 9, 2025

The authors present a rare case of exacerbation of psoriasiform eruptions in a patient who was prescribed sodium valproate for seizures.
, , , et al

Featured Cost and Economics Research

US Dementia Cases Will Double By 2060
news

January 14, 2025

New research predicts a dramatic rise in dementia, with the lifetime risk for Americans after age 55 now estimated at 42 percent.
ADHD Med Trials Often Miss the Mark
news

January 13, 2025

Persistent Adderall shortages and rising diagnoses highlight the mismatch between randomized controlled trials and real-world ADHD treatment.
Poor Sleep Linked to Mental Health Issues Through Brain Deficits
news

January 10, 2025

New research links poor sleep to deficits in brain regions that hinder memory control, which could exacerbate existing mental health issues.

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe